Plant derived active compounds as potential anti SARS-CoV-2 agents: an in-silico study

References

• Abdelli, I., Hassani, F., Bekkel Brikci, S., & Ghalem, S. (2020). In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by components harvested from Western Algeria. Journal of Biomolecular Structure & Dynamics, 1–14. https://doi.org/10.1080/07391102.2020.1763199
   Google Scholar
• Antalis, T. M., Bugge, T. H., & Wu, Q. (2011). Membrane-anchored serine proteases in health and disease. Progress in Molecular Biology and Translational Science, 99, 1–50. https://doi.org/10.1016/B978-0-12-385504-6.00001-4
   PubMed Web of Science ®Google Scholar
• Balkrishna, A., Pokhrel, S., Singh, H., Joshi, M., Mulay, V. P., Haldar, S., & Varshney, A (2021). Withanone from Withania somnifera attenuates SARS-CoV-2 RBD and host ACE2 interactions to rescue spike protein induced pathologies in humanized zebrafish model. Drug Design, Development and Therapy, 15, 1111–1133. https://doi.org/10.2147/DDDT.S292805
   PubMed Web of Science ®Google Scholar
• Cai, Y., Zhang, J., Xiao, T., Peng, H., Sterling, S. M., Walsh, R. M., Jr., Rawson, S., Rits-Volloch, S., & Chen, B. (2020). Distinct conformational states of SARS-CoV-2 spike protein. Science (New York, N.Y.), 369(6511), 1586–1592. https://doi.org/10.1126/science.abd4251
   PubMed Web of Science ®Google Scholar
• Case, D. A., Cheatham, T. E., Darden, T., Gohlke, H., Luo, R., Merz, K. M., Onufriev, A., Simmerling, C., Wang, B., & Woods, R. J. (2005). The Amber biomolecular simulation programs. Journal of Computational Chemistry, 26(16), 1668–1688. https://doi.org/10.1002/jcc.20290
   PubMed Web of Science ®Google Scholar
• Chandel, V., Raj, S., Rathi, B., & Kumar, D. (2020). In silico identification of potent COVID-19 main protease inhibitors from FDA approved antiviral compounds and active phytochemicals through molecular docking: A drug repurposing approach, Preprints. 7(3), 166–175. http://thesciencein.org/cbl.
   Google Scholar
• Choudhary, S., Malik, Y. S., & Tomar, S. (2020). Identification of SARS-CoV-2 cell entry inhibitors by drug repurposing using in silico structure-based virtual screening approach. Frontiers in Immunology, 11, 1664. https://doi.org/10.3389/fimmu.2020.01664
   PubMed Web of Science ®Google Scholar
• Coronavirus Update (Live): 154,815,600 cases and 3,236,104 deaths from COVID-19 Virus Pandemic – Worldometer. Retrieved May 4, 2021, from https://www.worldometers.info/coronavirus
   Google Scholar
• Devaux, C. A., Rolain, J.-M., & Raoult, D. (2020). ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. Journal of Microbiology, Immunology and Infection, 53(3), 425–435. https://doi.org/10.1016/j.jmii.2020.04.015
   Web of Science ®Google Scholar
• Dolinsky, T. J., Nielsen, J. E., McCammon, J. A., & Baker, N. A. (2004). PDB2PQR: An automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Research, 32(Web Server Issue), W665–W667. https://doi.org/10.1093/nar/gkh381
   PubMedGoogle Scholar
• Drew, E. D., & Janes, R. W. (2020). Identification of a druggable binding pocket in the spike protein reveals a key site for existing drugs potentially capable of combating Covid-19 infectivity. BMC Molecular and Cell Biology, 21(1), 1–13. https://doi.org/10.1186/s12860-020-00294-x
   PubMed Web of Science ®Google Scholar
• Elmezayen, A. D., Al-Obaidi, A., Şahin, A. T., & Yelekçi, K. (2020). Drug repurposing for coronavirus (COVID-19): In silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. Journal of Biomolecular Structure & Dynamics, 39(8), 2980–2913. https://doi.org/10.1080/07391102.2020.1758791
   PubMed Web of Science ®Google Scholar
• HDOCK Server. (2020). Retrieved July 28, from http://hdock.phys.hust.edu.cn
   Google Scholar
• Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., Müller, M. A., Drosten, C., & Pöhlmann, S. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 181(2), 271–280.e8. https://doi.org/10.1016/j.cell.2020.02.052 Epub 2020 Mar 5.
   PubMed Web of Science ®Google Scholar
• Hooper, J. D., Clements, J. A., Quigley, J. P., Antalis, T. M (2021). Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. The Journal of Biological Chemistry, 276(2), 857–860. https://doi.org/10.1074/jbc.R000020200
   Google Scholar
• Hornak, V., Abel, R., Okur, A., Strockbine, B., Roitberg, A., & Simmerling, C. (2006). Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins, 1565(3), 712–725. https://doi.org/10.1002/prot.21123
   Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38. https://doi.org/10.1016/0263-7855(96)00018-5
   PubMedGoogle Scholar
• Hussain, M., Jabeen, N., Amanullah, A., Baig, A. A., Aziz, B., Shabbir, S., Raza, F., & Uddin, N. (2020). Molecular docking between human TMPRSS2 and SARS-CoV-2 spike protein: Conformation and intermolecular interactions. AIMS Microbiology, 6(3), 350–360.
   PubMed Web of Science ®Google Scholar
• Indari, O., Jakhmola, S., Elangovan, M., & Jha, H. C. (2021). An update on antiviral therapy against SARS-CoV-2: How far have we come? Frontiers in Pharmacology, (11), 133. https://doi.org/10.3389/fphar.2021.632677
   Google Scholar
• Izaguirre, J. A., Catarello, D. P., Wozniak, J. M., & Skeel, R. D. (2001). Langevin stabilization of molecular dynamics. The Journal of Chemical Physics, 114(5), 2090–2098. https://doi.org/10.1063/1.1332996
   Web of Science ®Google Scholar
• Jakhmola, S., Hazarika, Z., Jha, A. N., & Jha, H. C. (2021). In silico analysis of antiviral phytochemicals efficacy against Epstein–Barr virus glycoprotein H. Journal of Biomolecular Structure and Dynamics, 1–14. https://doi.org/10.1080/07391102.2020.1871074
   Google Scholar
• Jakhmola, S., Indari, O., Baral, B., Kashyap, D., Varshney, N., Das, A., Chatterjee, S., & Jha, H. C. (2020). Comorbidity assessment is essential during COVID-19 treatment. Frontiers in Physiology, (11), 984. https://doi.org/10.3389/fphys.2020.00984
   PubMed Web of Science ®Google Scholar
• Jakhmola, S., Indari, O., Kashyap, D., Varshney, N., Rani, A., Sonkar, C., Baral, B., Chatterjee, S., Das, A., Kumar, R., & Jha, H. C. (2020). Recent updates on COVID-19: A holistic review. Heliyon, 6(12), e05706. https://doi.org/10.1016/j.heliyon.2020.e05706
   PubMed Web of Science ®Google Scholar
• Joshi, T., Joshi, T., Sharma, P., Mathpal, S., Pundir, H., Bhatt, V., & Chandra, S. (2020). In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking. European Review for Medical and Pharmacological Sciences, 24(8), 4529–4536. https://doi.org/10.26355/eurrev_202004_21036
   PubMed Web of Science ®Google Scholar
• Kalra, R. S., Kumar, V., Dhanjal, J. K., Garg, S., Li, X., Kaul, S. C., Sundar, D., & Wadhwa, R. (2021). COVID19-inhibitory activity of withanolides involves targeting of the host cell surface receptor ACE2: Insights from computational and biochemical assays. Journal of Biomolecular Structure & Dynamics, 1–14. https://doi.org/10.1080/07391102.2021.1902858
   Google Scholar
• Kozakov, D., Grove, L. E., Hall, D. R., Bohnuud, T., Mottarella, S. E., Luo, L., Xia, B., Beglov, D., & Vajda, S. (2015). The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins. Nature Protocols, 10(5), 733–755. https://doi.org/10.1038/nprot.2015.043
   PubMed Web of Science ®Google Scholar
• Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., Zhang, L., & Wang, X. (2020). Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature, 581(7807), 215–220. https://doi.org/10.1038/s41586-020-2180-5
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• Muralidharan, M., & Rao, G. H. R. (2020). Oxygen as a therapeutic drug: Hyperbaric oxygen therapy. Biomedical and Pharmacology Journal, 13(02), 521–528. https://doi.org/10.13005/bpj/1913
   Google Scholar
• Orlando, S. J., Santiago, Y., DeKelver, R. C., Freyvert, Y., Boydston, E. A., Moehle, E. A., Choi, V. M., Gopalan, S. M., Lou, J. F., Li, J., Miller, J. C., Holmes, M. C., Gregory, P. D., Urnov, F. D., & Cost, G. J. (2010). Zinc-finger nuclease-driven targeted integration into mammalian genomes using donors with limited chromosomal homology. Nucleic Acids Research, 38(15), e152. https://doi.org/10.1093/nar/gkq512
   PubMed Web of Science ®Google Scholar
• Ortega, J. T., Serrano, M. L., Pujol, F. H., & Rangel, H. R. (2020). Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis. EXCLI Journal, 19, 410–417. https://doi.org/10.17179/excli2020-1167
   PubMed Web of Science ®Google Scholar
• Patel, V. B., Clarke, N., Wang, Z., Fan, D., Parajuli, N., Basu, R., Putko, B., Kassiri, Z., Turner, A. J., & Oudit, G. Y. (2014). Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: A positive feedback mechanism in the RAS. Journal of Molecular and Cellular Cardiology, 66, 167–176. https://doi.org/10.1016/j.yjmcc.2013.11.017 Epub 2013 Dec 9
   PubMed Web of Science ®Google Scholar
• Patel, V. B., Zhong, J.-C., Grant, M. B., & Oudit, G. Y. (2016). Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure. Circulation Research, 118(8), 1313–1326. https://doi.org/10.1161/CIRCRESAHA.116.307708
   PubMed Web of Science ®Google Scholar
• Pierri, C. L. (2020). SARS-CoV-2 spike protein: Flexibility as a new target for figurehting infection. Signal Transduction and Targeted Therapy, 5(1), 1–3. https://doi.org/10.1038/s41392-020-00369-3
   PubMed Web of Science ®Google Scholar
• Pires, D. E. V., Blundell, T. L., & Ascher, D. B. (2015). pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry, 58(9), 4066–4072. https://doi.org/10.1021/acs.jmedchem.5b00104
   PubMed Web of Science ®Google Scholar
• PubChem. Retrieved from July 28, 2020, from https://pubchem.ncbi.nlm.nih.gov/
   Google Scholar
• RAMPAGE: Ramachandran Plot Assessment, v6.0, DOE‐MBI Structure Lab UCLA 2020. Retrieved June 11, 2021, from http://http://services.mbi.ucla.edu/SAVES/Ramachandran.
   Google Scholar
• Roe, D. R., & Cheatham, T. E. (2013). PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data. Journal of Chemical Theory and Computation, 9(7), 3084–3095. https://doi.org/10.1021/ct400341p
   PubMed Web of Science ®Google Scholar
• R. P. D. Bank. RCSB PDB: Homepage. Retrieved July 28, 2020, from https://www.rcsb.org/
   Google Scholar
• Ryckaert, J.-P., Ciccotti, G., & Berendsen, H. J. (1977). Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. Journal of Computational Physics, 23(3), 327–341. https://doi.org/10.1016/0021-9991(77)90098-5
   Web of Science ®Google Scholar
• Sager, A. A., Abood, Z. S., El-Amary, W. M., Bensaber, S. M., Al-Sadawe, I. A., Ermeli, N. B., Mohamed, S. B., Al-Forgany, M., Mrema, I. A., Erhuma, M., Hermann, A., & Gbaj, A. M. (2018). Design, synthesis and biological evaluation of some triazole Schiff's base derivatives as potential antitubercular agents. The Open Medicinal Chemistry Journal, 12, 48–59. https://doi.org/10.2174/1874104501812010048
   PubMedGoogle Scholar
• SAVES v5.0 - DOE-MBI Structure Lab UCLA. Retrieved July 28, 2020, from https://servicesn.mbi.ucla.edu/SAVES/
   Google Scholar
• Shah, B., Modi, P., & Sagar, R. (2020). In silico studies on therapeutic agents for COVID-19: Drug repurposing approach. Life Sciences, 252, 117652. https://doi.org/10.1016/j.lfs.2020.117652
   PubMed Web of Science ®Google Scholar
• Silva, D. R., Cássia, J. D., Sardi, O., Freires, I., Cristina, A., Pedro, B., & Rosalen, L. (2019). In silico approaches for screening molecular targets in Candida albicans: A proteomic insight into drug discovery and development. European Journal of Pharmacology, 842, 64–69. https://doi.org/10.1016/j.ejphar.2018.10.016
   PubMed Web of Science ®Google Scholar
• Sinha, S. K., Shakya, A., Prasad, S. K., Singh, S., Gurav, N. S., Prasad, R. S., & Gurav, S. S. (2020). An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets. Journal of Biomolecular Structure and Dynamics, 39(9), 3244–3255. https://doi.org/10.1080/07391102.2020.1762741
   PubMed Web of Science ®Google Scholar
• Sonkar, C., Kashyap, D., Varshney, N., Baral, B., & Jha, H. C. (2020). Impact of gastrointestinal symptoms in COVID-19: A molecular approach. SN Comprehensive Clinical Medicine, 2(12), 2658–2612. https://doi.org/10.1007/s42399-020-00619-z
   PubMedGoogle Scholar
• Stalin Raj, V., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., Thiel, V., Drosten, C., Rottier, P. J. M., Albert, D. M., Bosch, B. J., & Haagmans, B. L. (2013). Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature, 495(7440), 251–254. https://doi.org/10.1038/nature12005
   PubMed Web of Science ®Google Scholar
• Straughn, A. R., & Kakar, S. S. (2020). Withaferin A: A potential therapeutic agent against COVID-19 infection. Journal of Ovarian Research, 13(1), 1–5. https://doi.org/10.1186/s13048-020-00684-x
   Web of Science ®Google Scholar
• SwissADME. Retrieved July 28, 2020, from http://www.swissadme.ch/index.php
   Google Scholar
• Tallei, T. E., Tumilaar, S. G., Niode, N. J., Fatimawali, F., Kepel, B. J., Idroes, R., & Effendi, Y. (2020). Potential of plant bioactive compounds as SARS-CoV-2 main protease (Mpro) and spike (S) glycoprotein inhibitors: A molecular docking study. Medicine & Pharmacology, 2020,18. https://doi.org/10.1155/2020/6307457.
   Google Scholar
• Thunders, M., & Delahunt, B. (2020). Gene of the month: TMPRSS2 (transmembrane serine protease 2). Journal of Clinical Pathology, 73(12), 773–776. https://doi.org/10.1136/jclinpath-2020-206987
   PubMed Web of Science ®Google Scholar
• UniProt. Retrieved July 28, 2020, from http://www.uniprot.org/
   Google Scholar
• Vadapalli, J., Gallagher, V., Vanam, A., Motohashi, N., & Gollapudi, R. (2018). Integrated in silico docking and MoMA simulation approaches reveal Withaferin A, Withalongolides A and B as potent aldoketo reductase (AKR) 1C3 inhibitors. Journal of in Silico & in Vitro Pharmacology, 04, 4. https://doi.org/10.21767/2469-6692.10026
   Google Scholar
• Walls, A. C., Park, Y.-J., Alexandra Tortorici, M., Wall, A., McGuire, A. T., & Veesler, D. (2020). Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein, 181(2), 281–292.e6. https://doi.org/10.1101/2020.02.19.956581
   Google Scholar
• Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general amber force field. Journal of Computational Chemistry, 25(9), 1157–1174. https://doi.org/10.1002/jcc.20035
   PubMed Web of Science ®Google Scholar
• Waterhouse, A., Bertoni, M., Bienert, S., Studer, G., Tauriello, G., Gumienny, R., Heer, F. T., de Beer, T. A. P., Rempfer, C., Bordoli, L., Lepore, R., & Schwede, T. (2018). SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic Acids Research, 46(W1), W296–W303. https://doi.org/10.1093/nar/gky4
   PubMed Web of Science ®Google Scholar
• Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020). Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science (New York, N.Y.), 367(6483), 1260–1263. https://doi.org/10.1126/science.abb2507
   PubMed Web of Science ®Google Scholar
• Zhang, D.-H., Wu, K.-L., Zhang, X., Deng, S.-Q., & Peng, B. (2020). In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. Journal of Integrative Medicine, 18(2), 152–158. https://doi.org/10.1016/j.joim.2020.02.005
   PubMed Web of Science ®Google Scholar